Understand · Treat · Recover
Recurrence, Follow-up and Survivorship
Follow-up addresses both cancer recurrence and the physical and emotional effects of treatment.
For patients, families and caregivers worldwide. Approvals, access and care pathways vary by country. Evidence checked 21 October 2026.
This information is provided for general educational purposes and does not replace individualized medical advice. Diagnosis and treatment decisions should be made with a qualified healthcare team.
Chapter 19 of 20
What follow-up is for
Visits review symptoms, weight, nutrition, recovery, treatment complications and wellbeing. The schedule depends on original stage, treatment, remaining anatomy and local guidance. Tests should answer a useful clinical question. Routine intensive PET scanning or broad tumour-marker panels are not necessary for every person after curative treatment. Ask which tests are planned and what result would change care.
Symptoms between visits
Report persistent new swallowing difficulty, vomiting, unexplained weight loss, worsening pain, new swelling, bleeding or progressive fatigue. These do not always mean recurrence; nutritional deficiency, scar-related narrowing and other conditions are possible. Do not wait for a scheduled visit if symptoms are progressive or urgent.
If cancer returns
Local recurrence is near the original site; distant recurrence involves other organs or the peritoneum. Imaging, sometimes biopsy and biomarker reassessment guide treatment. A long disease-free interval and a limited recurrence may permit selected local treatment, but many recurrences require systemic therapy. Previous chemotherapy, immunotherapy, radiation and residual toxicities influence the next choice.
Long-term physical health
Monitor weight, B12, iron and other nutritional needs, especially after gastrectomy. Persistent reflux, diarrhea, dumping, neuropathy or fatigue should be addressed. Gradually increase physical activity, including strength and balance work as appropriate. Return to work may need shorter hours, meal breaks and access to food or medication. A survivorship summary helps primary-care clinicians understand the operation and lifelong needs.
Fear of recurrence and family adjustment
Anxiety around scans and new symptoms is common. Agreeing which symptoms to report and how results will be communicated can reduce uncertainty. Psychological support, peer groups and caregiver counselling may help. Relatives can support meals and appointments without making every conversation about cancer. Palliative care can assist with persistent symptoms at any stage; its involvement does not define prognosis.
What to keep in a survivorship plan
- Original diagnosis, stage, biomarker reports and surgery details.
- Treatment names, dates, major toxicities and any ongoing therapy.
- Nutrition and replacement schedule, including lifelong B12 when required.
- Follow-up responsibilities, planned investigations and urgent contacts.
- Personal goals for activity, work, relationships and emotional recovery.
Key takeaways
Survivorship care combines sensible surveillance with lifelong nutritional and emotional support.
Frequently asked questions
Does everyone need regular PET-CT?
No. Testing is individualised and should have a clear purpose.
Does a new symptom always mean recurrence?
No, but persistent or progressive changes deserve assessment.
Can recurrence still be treated?
Often yes. Options depend on its extent, biology and previous treatment.
Should nutrition monitoring stop after five years?
Not necessarily. Surgical changes can create lifelong needs.
Is fear of recurrence unusual?
No. Support and a clear follow-up plan can help.
Can exercise cause recurrence?
Appropriately adapted activity is generally helpful; discuss restrictions during recovery or with specific complications.